Literature DB >> 31310174

Follow-up of Incidentally Detected Pancreatic Cystic Neoplasms: Do Baseline MRI and CT Features Predict Cyst Growth?

Pallavi Pandey1, Ankur Pandey1, Yan Luo1, Mounes Aliyari Ghasabeh1, Pegah Khoshpouri1, Sanaz Ameli1, Anne Marie O'Broin-Lennon1, Marcia Canto1, Ralph H Hruban1, Michael S Goggins1, Christopher Wolfgang1, Ihab R Kamel1.   

Abstract

Background Incidental detection of pancreatic cystic neoplasm (PCN) has increased. Since a small percentage of PCNs possess malignant potential, management is challenging. The recently revised American College of Radiology (ACR) recommendations define PCN measurement and growth for different categories based on baseline cyst size. However, no data are available regarding PCN growth rate under the ACR-defined size categories. Purpose To assess growth of incidentally detected PCNs on long-term imaging follow-up using revised ACR recommendations and to evaluate the association between baseline imaging features and growth. Materials and Methods This retrospective study included PCNs with baseline imaging performed between January 2002 and May 2017, with two or more cross-sectional imaging studies performed at least 12 months apart. PCN assessment was based on ACR 2017 recommendations. Cyst features, including location, septations, and mural nodules and multiplicity, were noted. Time to cyst progression (growth by ACR criteria) was examined by using baseline PCN size, among other factors. Results A total of 646 cysts in 390 patients were followed up for a median of 50 months (range, 12-186 months). A total of 184 (28.5%) cysts increased in size, 52 (8.1%) decreased in size, and 410 (63.4%) remained stable. For groups in which baseline PCN size was smaller than 5 mm, 5-14 mm, 15-25 mm, and larger than 25 mm, growth was noted in seven (13.2%), 106 (28.9%), 49 (32.2%), and 22 (29.7%) cysts, respectively. ACR baseline size categories (subhazard ratio: 2.8 [5-14-mm PCN group], 3.4 [15-25-mm PCN group], and 2.7 [>25 mm group], as compared with the <5 mm PCN group; P < .05 for each) demonstrated association with growth. Presence of mural nodules, septations, or lesion multiplicity failed to demonstrate association with growth. Among PCNs smaller than 5 mm at baseline, 100% of PCNs at 3-year follow-up and 94.2% of PCNs at 5-year follow-up were likely to remain stable. Conclusion American College of Radiology baseline size category of 15-25-mm pancreatic cystic neoplasms (PCNs) demonstrated the highest (3.1 times) likelihood of growth, as compared with the category of PCNs smaller than 5 mm. PCNs smaller than 5 mm at baseline did not demonstrate growth at 3-year imaging follow-up. © RSNA, 2019 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2019        PMID: 31310174      PMCID: PMC6716563          DOI: 10.1148/radiol.2019181686

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  29 in total

1.  Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Stefan Fritz; Moritz Schirren; Miriam Klauss; Frank Bergmann; Thilo Hackert; Werner Hartwig; Oliver Strobel; Lars Grenacher; Markus W Büchler; Jens Werner
Journal:  Surgery       Date:  2012-07-06       Impact factor: 3.982

Review 2.  The cost of dichotomising continuous variables.

Authors:  Douglas G Altman; Patrick Royston
Journal:  BMJ       Date:  2006-05-06

3.  Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan.

Authors:  Hiroyuki Maguchi; Satoshi Tanno; Nobumasa Mizuno; Keiji Hanada; Go Kobayashi; Takashi Hatori; Yoshihiko Sadakari; Taketo Yamaguchi; Kosuke Tobita; Ryuichiro Doi; Akio Yanagisawa; Masao Tanaka
Journal:  Pancreas       Date:  2011-04       Impact factor: 3.327

4.  The natural history of the incidentally discovered small simple pancreatic cyst: long-term follow-up and clinical implications.

Authors:  Stephen J Handrich; David M Hough; Joel G Fletcher; Michael G Sarr
Journal:  AJR Am J Roentgenol       Date:  2005-01       Impact factor: 3.959

5.  American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts.

Authors:  Santhi Swaroop Vege; Barry Ziring; Rajeev Jain; Paul Moayyedi
Journal:  Gastroenterology       Date:  2015-04       Impact factor: 22.682

6.  Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.

Authors:  Marcia Irene Canto; Ralph H Hruban; Elliot K Fishman; Ihab R Kamel; Richard Schulick; Zhe Zhang; Mark Topazian; Naoki Takahashi; Joel Fletcher; Gloria Petersen; Alison P Klein; Jennifer Axilbund; Constance Griffin; Sapna Syngal; John R Saltzman; Koenraad J Mortele; Jeffrey Lee; Eric Tamm; Raghunandan Vikram; Priya Bhosale; Daniel Margolis; James Farrell; Michael Goggins
Journal:  Gastroenterology       Date:  2012-01-12       Impact factor: 22.682

7.  Estimation of the prevalence of asymptomatic pancreatic cysts in the population of San Marino.

Authors:  Nicola Zanini; Marco Giordano; Elia Smerieri; Giulio Cipolla d'Abruzzo; Marilyn Guidi; Giorgio Pazzaglini; Fiorella De Luca; Giorgia Chiaruzzi; Giovanni Vitullo; Paolo Piva; Raffaele Lombardi; Elio Jovine; Marino Gatti; Giovanni Landolfo
Journal:  Pancreatology       Date:  2015-05-21       Impact factor: 3.996

8.  Incidental cystic neoplasms of pancreas: what is the optimal interval of imaging surveillance?

Authors:  Ananya Das; Christopher D Wells; Cuong C Nguyen
Journal:  Am J Gastroenterol       Date:  2008-06-28       Impact factor: 10.864

9.  Prevalence of unsuspected pancreatic cysts on MDCT.

Authors:  Thomas A Laffan; Karen M Horton; Alison P Klein; Bruce Berlanstein; Stanley S Siegelman; Satomi Kawamoto; Pamela T Johnson; Elliot K Fishman; Ralph H Hruban
Journal:  AJR Am J Roentgenol       Date:  2008-09       Impact factor: 3.959

10.  Incidental, Small (< 3 cm), Unilocular, Pancreatic Cysts: Factors That Predict Lesion Progression during Imaging Surveillance.

Authors:  Go Eun Kim; Sang Soo Shin; Jin Woong Kim; Suk Hee Heo; Hyo Soon Lim; Chung Hwan Jun; Yong Yeon Jeong
Journal:  Korean J Radiol       Date:  2017-09-21       Impact factor: 3.500

View more
  5 in total

1.  Automated Identification and Measurement Extraction of Pancreatic Cystic Lesions from Free-Text Radiology Reports Using Natural Language Processing.

Authors:  Rikiya Yamashita; Kristen Bird; Philip Yue-Cheng Cheung; Johannes Hugo Decker; Marta Nicole Flory; Daniel Goff; Linda Nayeli Morimoto; Andy Shon; Andrew Louis Wentland; Daniel L Rubin; Terry S Desser
Journal:  Radiol Artif Intell       Date:  2021-12-22

2.  Side-branch intraductal papillary mucinous neoplasms of the pancreas: outcome of MR imaging surveillance over a 10 years follow-up.

Authors:  Piero Boraschi; Gaia Tarantini; Francescamaria Donati; Paola Scalise; Rosa Cervelli; Davide Caramella
Journal:  Eur J Radiol Open       Date:  2020-08-21

3.  Opportunistic Detection for Pancreatic Cystic Lesions During Chest Multidetector CT Scans for Lung Cancer Screening.

Authors:  Xin Chen; Zhicheng Yu; Jianhua Wang; Wenjing Cui; Can Cui; Yajie Wang; Yongkang Liu; Hao Zhou; Cheng Wang; Zhongqiu Wang; Xiao Chen
Journal:  Cancer Manag Res       Date:  2021-10-02       Impact factor: 3.989

4.  Characteristics and outcomes of anterior mediastinal cystic lesions diagnosed on chest MRI: implications for management of cystic lesions.

Authors:  Sang Min Lee; Ho Yun Lee; Jooae Choe; Yura Ahn; Chu Hyun Kim; Joon Beom Seo
Journal:  Insights Imaging       Date:  2022-08-17

5.  Automated Detection of Pancreatic Cystic Lesions on CT Using Deep Learning.

Authors:  Lorraine Abel; Jakob Wasserthal; Thomas Weikert; Alexander W Sauter; Ivan Nesic; Marko Obradovic; Shan Yang; Sebastian Manneck; Carl Glessgen; Johanna M Ospel; Bram Stieltjes; Daniel T Boll; Björn Friebe
Journal:  Diagnostics (Basel)       Date:  2021-05-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.